Journal Name: Current Trends in Vaccines and Vaccinology
ISSN: 2631-8970
DOI: 10.31021
Editor-in-Chief: Jianxun (Jim) Song
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
The Current Trends in Vaccines and Vaccinology (CTVV) is an international, peer-reviewed, open access journal published by Boffin Access Limited. The journal is dedicated to advancing the science, technology, and clinical application of vaccines. It provides a trusted global platform for researchers, clinicians, immunologists, and public health experts to share innovations that enhance disease prevention and global health security.
Vaccinology has transformed modern medicine by controlling infectious diseases and preventing epidemics. With the rise of novel pathogens, pandemics, and the need for innovative immunization strategies, CTVV serves as a critical source of cutting-edge research, evidence-based practices, and policy insights.
CTVV publishes original research articles, reviews, case studies, short communications, perspectives, and clinical trial reports across diverse areas, including:
Vaccine design, development, and production technologies
Novel vaccine platforms (mRNA, DNA, viral vector, nanoparticle, peptide-based)
Adjuvants and immunomodulatory agents
Pediatric, maternal, and adult immunization programs
Cancer vaccines, therapeutic vaccines, and personalized immunization approaches
Vaccine safety, efficacy, and regulatory science
Global vaccination strategies and public health policies
Challenges in vaccine delivery, distribution, and equity
Antigen discovery and immune response mechanisms
Emerging infectious diseases and pandemic preparedness
Vaccinology in veterinary medicine and zoonotic diseases
High Relevance – Covers both basic research and applied vaccinology with global health implications.
Rigorous Peer Review – Double-blind review ensures academic integrity and reliability.
Rapid and Open Access – Accepted manuscripts are quickly published online for worldwide accessibility.
Global Readership – Widely disseminated to researchers, healthcare providers, policymakers, and vaccine developers.
Multidisciplinary Collaboration – Bridges immunology, biotechnology, clinical medicine, and public health.
Author Rights – Authors retain copyright under Creative Commons licensing, promoting maximum reuse and visibility.
Enhanced Formats – Articles may be published with supplementary datasets, clinical trial data, or multimedia.
CTVV adheres to internationally recognized ethical guidelines, including COPE and ICMJE principles. The journal is committed to transparency, reproducibility, and responsible dissemination of scientific knowledge that impacts public health policies and practices.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.